ADAPTIVE AND INNATE IMMUNE RESPONSES
TRIGGERED TO NEUTRALIZE GASTRIN HORMONES
AS A THERAPY FOR GI CANCERS

ADVISORY BOARD
  • Prof. Dr. JOLANDA DE VRIES – Radboud University, Nijmegen, the Netherlands – Prof. of Tumor Immunology; expert in plasmacytoid dendritic cells
  • Prof. Dr. REINGARD GRABHERR – University of Agricultural Sciences, Vienna, Austria – Prof. of Biotechnology; expert in protein engineering
  • Prof. DANIEL D. VON HOFF, M.D., F.A.C.P., is currently Physician in Chief and Director of Translational Research at TGen (Translational Genomics Research Institute) in Phoenix, Arizona. He is also Chief Scientific Officer for US Oncology and for Scottsdale Healthcare's Clinical Research Institute.   He is also a Clinical Professor of Medicine, University of Arizona.
  • Prof. GRAHAM DOCKRAY, Emeritus Professor of Physiology at the University of Liverpool will join us on the call.  By way of introduction, Graham is a fellow of the Academy of Medical Sciences and an honorary Fellow of the Royal College of Physicians. He is also a member of the Physiological Society, and the British Society of Gastroenterology and is on the Editorial Boards of Regulatory Peptides and Autonomic Neuroscience: Basic and Clinical
  • STEVEN DALE WEITMAN , M.D, Ph.D., Associate Director of Clinical Research, University of Texas Health Science Center, San Antonio, TX
  • PETER LAING, BScHons, PhD., Director Liposomal Glycobiology and Hepatology Product Development, United Therapeutics Europe Ltd.
[Sleeker_special_clear]